SURI vs. BOUT ETF Comparison
Comparison of Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (SURI) to Innovator IBD Breakout Opportunities ETF (BOUT)
SURI
Simplify Exchange Traded Funds Simplify Propel Opportunities ETF
SURI Description
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$23.15
Average Daily Volume
5,497
15
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.Grade (RS Rating)
Last Trade
$40.14
Average Daily Volume
2,990
44
Performance
| Period | SURI | BOUT |
|---|---|---|
| 30 Days | -1.79% | 7.95% |
| 60 Days | -1.24% | 9.94% |
| 90 Days | -0.03% | 9.81% |
| 12 Months | 41.29% | 32.83% |
0 Overlapping Holdings
| Symbol | Grade | Weight in SURI | Weight in BOUT | Overlap |
|---|
SURI Underweight 44 Positions Relative to BOUT
| Symbol | Grade | Weight | |
|---|---|---|---|
| PACS | F | -4.48% | |
| MS | A | -4.47% | |
| LBRDK | C | -4.44% | |
| NEM | D | -4.42% | |
| VIK | B | -4.39% | |
| EXPE | B | -4.28% | |
| EQIX | A | -4.25% | |
| AHR | A | -4.24% | |
| IDCC | B | -4.01% | |
| ETN | A | -3.82% | |
| SPGI | C | -3.81% | |
| EQH | C | -3.78% | |
| CRM | B | -3.73% | |
| BAH | F | -3.73% | |
| DVA | C | -3.71% | |
| PGR | A | -3.63% | |
| CRDO | B | -2.87% | |
| VRNS | D | -2.61% | |
| ULS | B | -2.59% | |
| IR | B | -2.49% | |
| DT | D | -2.49% | |
| NMIH | C | -2.44% | |
| ONON | A | -2.35% | |
| COLL | F | -2.23% | |
| TSM | B | -1.31% | |
| TBBK | B | -1.28% | |
| NOW | A | -1.27% | |
| CDNA | D | -1.24% | |
| SCCO | F | -1.22% | |
| SN | D | -1.2% | |
| TCOM | B | -1.14% | |
| BEKE | D | -1.06% | |
| ROAD | B | -0.45% | |
| AXON | A | -0.43% | |
| TPH | D | -0.42% | |
| IBKR | A | -0.42% | |
| CWAN | B | -0.42% | |
| AVGO | D | -0.42% | |
| ALKT | B | -0.42% | |
| GMED | A | -0.41% | |
| CORT | B | -0.41% | |
| ACGL | C | -0.4% | |
| PLMR | A | -0.39% | |
| JD | D | -0.38% |
SURI: Top Represented Industries & Keywords
BOUT: Top Represented Industries & Keywords
Compare ETFs
